Industry

Fielmann Group Creates U.S. Optometry Advisory Board, Tags NECO’s Dr. Howard Purcell as Chairman

Vision Monday6d ago1 min read

HAMBURG, Germany and GREEN BAY, Wis.—Fielmann Group, a leading global vision care and eyewear provider, has announced the formation of a dedicated optometry advisory board for the U.S. market and has named Howard Purcell, OD, president and CEO of the New England College of Optometry (NECO), as chairman. The board will provide strategic guidance and medical expertise, supporting both Fielmann USA and Fielmann Group executive management in translating the company’s patient-centric philosophy to the U.S. market, the announcement stated.

Read full article on Vision Monday

AI Summary

Quick Take

Fielmann Group has established a dedicated U.S. Optometry Advisory Board to guide its American expansion, appointing Dr. Howard Purcell, President and CEO of the New England College of Optometry (NECO), as its inaugural chairman. The board will provide strategic and medical oversight to help the German-based eyewear giant adapt its patient-centric business model to the U.S. market.

Why It Matters

Fielmann Group is a dominant force in European eye care that has recently pivoted toward aggressive growth in the United States. By securing a high-profile academic leader like Dr. Purcell, the company is signaling a desire to align its retail operations with U.S. clinical standards and professional education. This move suggests that Fielmann intends to compete on clinical reputation and professional integration, rather than relying solely on the price-competitive retail strategies that defined its early success in Europe.

Key Details

Dr. Howard Purcell, OD, will lead the board while maintaining his role as President and CEO of the New England College of Optometry.
The board is tasked with providing medical expertise and strategic guidance to both Fielmann USA and the global executive management team in Hamburg.
A primary objective is the translation of Fielmann’s 'patient-centric philosophy' into the specific regulatory and professional context of the U.S. eye care market.
The formation of the board follows Fielmann's recent entry into the U.S. market through the acquisition of regional players like SVS Vision and Eye-Care Center.

Who's Affected

Practice OwnersOptometristsOptometric EducatorsOptical Retail Executives

What's Next

The board is expected to play a critical role in shaping Fielmann's clinical service delivery and doctor recruitment strategies as the company scales. Further appointments to the advisory board from across the U.S. eye care industry are likely to follow as the group formalizes its medical governance.

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.